Low impairment of physical function (lower HAQ-DI score), greater pain, greater CRP concentration, polyarthritis without inflammation of large joints, prior treatment with >2 DMARDs, current treatment with SSZ but not glucocorticoids and male sex were factors that increased the chance of achieving substantial clinical improvements. This evidence concerns the gene CRP and polyarticular arthritis.